Evidence map›Paper›PMID 42015696›Full record

Observational studyZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2026

[Incidence of severe cancer therapy-related thrombocytopenia and associated factors in children].

Lin Chen, Nan-Ping Shen, Meng-Xue He, Xu-Jing Xu, Ji-Wen Sun, Bi-Yu Shen

Abstract readEnglish AbstractObservational Study
In one paragraph

Observational study in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lin ChenDepartment of Nursing, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Nan-Ping Shen
Meng-Xue He
Xu-Jing Xu
Ji-Wen Sun
Bi-Yu Shen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the incidence of severe cancer therapy-related thrombocytopenia (CTRT) and associated factors in children.

methodsA prospective observational study was conducted among 1 047 pediatric inpatients with cancer at Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicinefrom November 2023 to August 2024. Patients were divided into two groups based on the occurrence of severe CTRT. Multivariable logistic regression analysis was used to identify risk factors for severe CTRT.

resultsSevere CTRT occurred in 343 patients (32.76%). Multivariable logistic regression analysis showed that disease relapse, history of severe CTRT, nutritional risk, use of >3 antineoplastic agents, inclusion of platinum-based agents/cytarabine/anthracyclines in the regimen, and pre-treatment platelet count <100×10⁹/L were significantly associated with severe CTRT (

conclusionsThe incidence of severe CTRT in children is relatively high, and it is influenced by multiple factors including medical history (relapse, previous severe CTRT), treatment regimen (>3 antineoplastic agents, inclusion of platinum-based agents/cytarabine/anthracyclines), and health status (nutritional risk, pre-treatment platelet count <100×10⁹/L). High-risk children should be identified through comprehensive assessment of medical history, health condition, and treatment regimen to provide timely preventive and supportive care.

Indexed as

Antineoplastic AgentsNeoplasmsThrombocytopeniaAdolescentChildChild, PreschoolFemaleHumansIncidenceInfantLogistic ModelsMaleProspective StudiesRisk FactorsAntineoplastic AgentsChildRisk factorSevere cancer therapy-related thrombocytopenia

Identifiers

PMID42015696
PMCPMC13108938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.